ResMed Inc. (RMD) compared with its closest peers (BSX, BDX, DXCM, MDLN, WST): P/E 21.9 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Boston Scientific Corporation (BSX) | $71.58B | 19.5 |
| Becton, Dickinson and Company (BDX) | $51.12B | 54.3 |
| DexCom, Inc. (DXCM) | $34.04B | 34.1 |
| Medline Inc. (MDLN) | $28.16B | 29.8 |
| West Pharmaceutical Services, Inc. (WST) | $25.00B | 43.7 |
| Solventum Corporation (SOLV) | $15.35B | 10.7 |
| Baxter International Inc. (BAX) | $13.65B | -10.2 |
| Penumbra, Inc. (PEN) | $12.76B | 87.5 |
| Globus Medical, Inc. (GMED) | $11.51B | 21.5 |
| Glaukos Corporation (GKOS) | $10.89B | -34.4 |
| Stock P/E | 21.9 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 1.4% |
| vs Industry | -33.4% |
RMD overview · RMD earnings · RMD financials · RMD KPIs · RMD investor relations · RMD ownership · RMD filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.